Evaluation of the quantitative accuracy of a commercially available positron emission mammography scanner

Medical Physics

Volumn 38, Issue 4, 2011, Pages 2132-2139

  Springer, Adam ^a   Mawlawi, Osama R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

breast imaging; PEM; positron emission mammography; quantitative imaging

Indexed keywords

ELECTRONS; ERRORS; IMAGE RECONSTRUCTION; MEDICAL IMAGING; PIXELS; POSITRONS; SCANNING;

ACTIVITY CONCENTRATION; BACKGROUND RATIO; BREAST IMAGING; GELATIN PHANTOMS; PHANTOM THICKNESS; POSITRON EMISSION MAMMOGRAPHY; QUANTITATIVE ACCURACY; QUANTITATIVE IMAGING;

PHANTOMS;

EID: 79953658422     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3560881     Document Type: Article

References (33)

1. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, 2010, Vol. 2010.
2. L. Tabár, B. Vitak, H.-H. Chen, M.-F. Yen, S. W. Duffy, and R. A. Smith, "Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast carcinoma mortality," Cancer 91(9), 1724-1731 (2001).
3. The Swedish Organized Service Screening Evaluation Group, "Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data," Cancer Epidemiol. Biomarkers Prev. 15(1), 45-51 (2006).
4. M. T. Mandelson, N. Oestreicher, P. L. Porter, D. White, C. A. Finder, S. H. Taplin, and E. White, "Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers," J. Natl. Cancer Inst. 92(13), 1081-1087 (2000).
5. T. M. Kolb, J. Lichy, and J. H. Newhouse, "Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27,825 patient evaluations," Radiology 225(1), 165-175 (2002).
6. W. A. Berg et al., "Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer," JAMA, J. Am. Med. Assoc. 299(18), 2151-2163 (2008).
7. J. de Bresser, B. de Vos, F. van der Ent, and K. Hulsewe, "Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: A systematic review," Eur. J. Surg. Oncol. 36(2), 114-119 (2010).
8. S. G. Orel and M. D. Schnall, "MR imaging of the breast for the detection, diagnosis, and staging of breast cancer," Radiology 220(1), 13-30 (2001).
9. F. Bénard and É. Turcotte, "Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography," Breast Cancer Res. 7(4), 153-162 (2005).
10. M. Liberman, F. Sampalis, D. S. Mulder, and J. S. Sampalis, "Breast cancer diagnosis by scintimammography: A meta-analysis and review of the literature," Breast Cancer Res. Treat. 80(1), 115-126 (2003).
11. M. K. O'Connor, S. W. Phillips, C. B. Hruska, D. J. Rhodes, and D. A. Collins, "Molecular breast imaging: Advantages and limitations of a scintimammographic technique in patients with small breast tumors," Breast J. 13(1), 3-11 (2007).
12. C. Rose, J. Dose, and N. Avril, "Positron emission tomography for the diagnosis of breast cancer," Nucl. Med. Commun. 23(7), 613-618 (2002).
13. S. Carkaci, H. A. Macapinlac, M. Cristofanilli, O. Mawlawi, E. Rohren, A. M. Gonzalez Angulo, S. Dawood, E. Resetkova, H. T. Le-Petross, and W. T. Yang, "Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: Preliminary data," J. Nucl. Med. 50(2), 231-238 (2009).
14. J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, "Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose," J. Clin. Oncol. 27(4), 535-541 (2009).
15. M. Schegerin, A. N. Tosteson, P. A. Kaufman, K. D. Paulsen, and B. W. Pogue, "Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective," Breast Cancer Res. Treat. 114(3), 537-547 (2009).
16. W. A. Berg, I. N. Weinberg, D. Narayanan, M. E. Lobrano, E. Ross, L. Amodei, L. Tafra, L. P. Adler, J. Uddo, W. Stein III, and E. A. Levine, "High-resolution fluorodeoxyglucose positron emission tomography with compression ('positron emission mammography') is highly accurate in depicting primary breast cancer," Breast J. 12(4), 309-323 (2006).
17. S. L. Bowen et al., "Initial characterization of a dedicated breast PET/CT scanner during human imaging," J. Nucl. Med. 50(9), 1401-1408 (2009).
18. R. R. Raylman, S. Majewski, R. Wojcik, A. G. Weisenberger, B. Kross, and V. Popov, "Corrections for the effects of accidental coincidences, Compton scatter, and object size in positron emission mammography (PEM) imaging," IEEE Trans. Nucl. Sci. 48(3), 913-923 (2001).
19. C. J. Thompson, K. Murthy, I. N. Weinberg, and F. Mako, "Feasibility study for positron emission mammography," Med. Phys. 21(4), 529-538 (1994).
20. I. N. Weinberg, D. Beylin, V. Zavarzin, S. Yarnall, P. Y. Stepanov, E. Anashkin, D. Narayanan, S. Dolinsky, K. Lauckner, and L. P. Adler, "Positron emission mammography: High-resolution biochemical breast imaging," Technol. Cancer Res. Treat. 4(1), 55-60 (2005).
21. L. MacDonald, J. Edwards, T. Lewellen, D. Haseley, J. Rogers, and P. Kinahan, "Clinical imaging characteristics of the positron emission mammography camera: PEM Flex Solo II," J. Nucl. Med. 50(10), 1666-1675 (2009).
22. N. K. Doshi, Y. Shao, R. W. Silverman, and S. R. Cherry, "Design and evaluation of an LSO PET detector for breast cancer imaging," Med. Phys. 27(7), 1535-1543 (2000).
23. L. Tafra et al., "Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer," Am. J. Surg. 190(4), 628-632 (2005).
24. L. Weidong, E. Anashkin, and C. G. Matthews, "Performance evaluation of a PEM scanner using the NEMA NU 4 - 2008 Small Animal PET standards," IEEE Trans. Nucl. Sci. 57(1), 94-103 (2008).
25. L. Macdonald, J. Edwards, T. Lewellen, J. Rogers, and P. Kinahan, "Clinical imaging characteristics of the positron emission mammography PEM Flex Solo II," IEEE Nuclear Science Symposium Conference Record, Vol. 11, pp. 4494-4501, 2008.
26. K. R. Zasadny and R. L. Wahl, "Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction," Radiology 189(3), 847-850 (1993).
27. R. L. Wahl, H. Jacene, Y. Kasamon, and M. A. Lodge, "From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors," J. Nucl. Med. 50(1), 122S-150S (2009).
28. D. L. Bailey and S. R. Meikle, "A convolution-subtraction scatter correction method for 3D PET," Phys. Med. Biol. 39(3), 411-424 (1994).
29. Positron Emission Tomography, edited by D. M. Bailey D. W. Townsend, P. E. Valk, and M. N. Maisey (Springer-Verlag, London, 2005).
30. C. C. Watson, M. E. Casey, B. Bendriem, J. P. Carney, D. W. Townsend, S. Eberl, S. Meikle, and F. P. Difilippo, "Optimizing injected dose in clinical PET by accurately modeling the counting-rate response functions specific to individual patient scans," J. Nucl. Med. 46(11), 1825-1834 (2005).
31. K. Murthy, D. Jolly, M. Aznar, C. J. Thompson, P. Sciascia, A. Loutfi, R. Lisbona, and J. H. Gagnon, "Quantification in positron emission mammography (PEM) with planar detectors: Contrast resolution measurements using a custom breast phantom and novel sperical hot-spots," IEEE Trans. Nucl. Sci. 46(6), 2192-2196 (1999).
32. R. R. Raylman, S. Majewski, R. Wojcik, A. G. Weisenberger, B. Kross, V. Popov, and H. A. Bishop, "The potential role of positron emission mammography for detection of breast cancer. A phantom study," Med. Phys. 27(8), 1943-1954 (2000).
33. A. Springer and O. R. Mawlawi (private communication).